Finance

Lists
688266:SHA
Suzhou Zelgen Biopharmaceuticals Co Ltd
96,66 CN¥
+1,75%
(+1,66) 1D
16 հոկ, 15:00:02 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688266...
Open
96,00 CN¥
High
99,98 CN¥
Low
96,00 CN¥
Mkt. cap
25,59 մլրդ
Avg. vol.
3,44 մլն
Volume
3,02 մլն
P/E ratio
46,53
52-wk high
160,00 CN¥
52-wk low
75,10 CN¥
EPS
2,08 CN¥
No. of employees
1 հզր
Open
96,00 CN¥
High
99,98 CN¥
Low
96,00 CN¥
Mkt. cap
25,59 մլրդ
Avg. vol.
3,44 մլն
Volume
3,02 մլն
P/E ratio
46,53
52-wk high
160,00 CN¥
52-wk low
75,10 CN¥
EPS
2,08 CN¥
No. of employees
1 հզր
News stories
From web sources and news partners
About Suzhou Zelgen Biopharmaceuticals Co Ltd
CEO-
Employees1,06 հզր
Founded18 մրտ, 2009 թ.
Headquarters-
Sector-
Websitezelgen.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
217,79 մլն
217,04 մլն
905,39 մլն
299,99 մլն
Cost of goods sold
14,54 մլն
25,03 մլն
27,04 մլն
42,87 մլն
Cost of revenue
14,54 մլն
25,03 մլն
27,04 մլն
42,87 մլն
Research and development expenses
106,28 մլն
127,13 մլն
92,28 մլն
107,25 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
128,56 մլն
160,34 մլն
151,23 մլն
165,74 մլն
Operating expense
208,28 մլն
315,51 մլն
247,77 մլն
276,72 մլն
Total operating expenses
222,82 մլն
340,53 մլն
274,81 մլն
319,59 մլն
Operating income
-5,03 մլն
-123,49 մլն
630,58 մլն
-19,61 մլն
Other non operating income
-96,86 հզր
279,05 հզր
-6,83 մլն
6,52 մլն
EBT including unusual items
-20,90 մլն
-70,34 մլն
631,77 մլն
6,88 մլն
EBT excluding unusual items
5,30 մլն
-118,30 մլն
631,73 մլն
-15,57 մլն
Income tax expense
-877,77 հզր
-805,16 հզր
-841,97 հզր
-522,57 հզր
Effective tax rate
4,20%
1,14%
-0,13%
-7,60%
Other operating expenses
-26,77 մլն
29,52 մլն
2,33 մլն
2,86 մլն
Net income
-20,61 մլն
-69,53 մլն
632,61 մլն
7,40 մլն
Net profit margin
-9,46%
-32,03%
69,87%
2,47%
Earnings per share
-
-
-
-
Interest and investment income
13,73 մլն
12,79 մլն
13,97 մլն
14,97 մլն
Interest expense
-3,35 մլն
-6,97 մլն
-6,00 մլն
-5,31 մլն
Net interest expenses
10,38 մլն
5,82 մլն
7,98 մլն
9,67 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
5,70 մլն
-113,00 մլն
641,07 մլն
-11,51 մլն
Gain or loss from assets sale
810,00
-810,00
-
19,99 հզր
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps